Coles, Theresa M. http://orcid.org/0000-0003-2941-8999
Lucas, Nicole
McFatrich, Molly
Henke, Debra
Ridgeway, Jennifer L.
Behnken, Emma M.
Weinfurt, Kevin
Reeve, Bryce B.
Corneli, Amy
Dunlay, Shannon M.
Spertus, John A.
Lin, Li
PiƱa, Ileana L.
Bocell, Fraser D.
Tarver, Michelle E.
Dohse, Heidi
Saha, Anindita
Caldwell, Brittany
Funding for this research was provided by:
Office of Women's Health (75F40119C10080)
Article History
Accepted: 7 October 2022
First Online: 2 November 2022
Declarations
:
: JS owns the copyright to the KCCQ and receives license fees for the KCCQ. JS receives consulting fees from Bayer, Imbria Pharmaceuticals, Merck, Novartis, Bristol Meyers Squibb, Janssen, Terumo, and United Healthcare. JS is supported in grants from Abbott Vascular, Janssen and Bristol Meyers Squibb, and is on the Board of Directors for Blue Cross Blue Shield of Kansas City. RM received research support and honoraria from Abbott, American Regent, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim/Eli Lilly, Boston Scientific, Cytokinetics, Fast BioMedical, Gilead, Innolife, Medtronic, Merck, Novartis, Relypsa, Respicardia, Roche, Sanofi, Vifor, and Windtree Therapeutics. TC received research support from Merck and has a consulting agreement with Regenxbio. LL, KW, BR, IP, FB, MT, AS, DH, and BC have no competing interests to disclose.
: The study was approved by Duke University (coordinating center) and Mayo Clinic institutional review boards.
: Participants were verbally consented using a verbal script. A copy of the consent form was sent to patients who enrolled in the study.
: All authors read and approved the final manuscript. All authors also agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Free to read: This content has been made available to all.